Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy

Skin Cancer

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report

Surg Case Rep.

Yasuda K, Tanaka T, Ishihara S, Otani K, Nishikawa T, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Masui Y, Shintani Y, Watanabe T

doi: 10.1186/s40792-017-0370-7.

Endocrine and Neuroendocrine Tumors (NET)Skin Cancer

Long-Term Sustained Disease Control With Immunotherapy in Chemotherapy-Refractory Merkel Cell Carcinoma

healthbook TIMES Oncology Hematology

Zihlera D, Vollmera K, Cozzio A

doi: 10.36000/hbT.OH.2019.01.003

Skin Cancer

Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature

J Immunother.

Khoury ZH, Hausner PF, Idzik-Starr CL, Frykenberg MRA, Brooks JK, Dyalram D, Basile JR, Younis RH

doi: 10.1097/CJI.

Skin Cancer

Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report

J Hematol Oncol.

Uemura M, Trinh VA, Haymaker C, Jackson N, Kim DW, Allison JP, Sharma P, Vence L, Bernatchez C, Hwu P, Diab A

doi: 10.1186/s13045-016-0309-7.

Skin Cancer

Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial

Cancer Immunol Immunother.

Ascierto PA, Vanella V, Grimaldi AM, Lucia F, Palla M, Simeone E, Mozzillo N

doi: 10.1007/s00262-016-1898-2.

Genitourinary CancerLung, Respiratory and Thoracic CancerSkin CancerLymphoma

Malignant peripheral nerve sheath tumor in a patient with BAP1 tumor predisposition syndrome: case report

World Neurosurg.

Kaszuba MC, Pulido JS, Folpe AL, Pichurin PN, Goodenberger ML, Spinner RJ

doi: 10.1016/j.wneu.2017.10.064.

Skin Cancer

Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma

Melanoma Res.

Yip RHL, Lee LH, Schaeffer DF, Horst BA, Yang HM

doi: 10.1097/CMR.

SPECIAL REPORT

Genitourinary CancerLung, Respiratory and Thoracic CancerSkin Cancer

Meet the Expert

doi: 10.1056/NEJMoa1504627 (2015).

Gastrointestinal CancerLung, Respiratory and Thoracic CancerSkin Cancer

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors – an autopsy study

J Immunother Cancer.

Koelzer VH, Rothschild SI, Zihler D, Wicki A, Willi B, Willi N, Voegeli M, Cathomas G, Zippelius A, Mertz KD

doi: 10.1186/s40425-016-0117-1.

Related content

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report

Long-Term Sustained Disease Control With Immunotherapy in Chemotherapy-Refractory Merkel Cell Carcinoma

Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature

Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report

Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial

Malignant peripheral nerve sheath tumor in a patient with BAP1 tumor predisposition syndrome: case report

Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma

Meet the Expert

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors – an autopsy study